article thumbnail

STAT+: Mayo Clinic to spend $5 billion on tech-heavy redesign of its Minnesota campus

STAT

Mayo Clinic will spend $5 billion to reinvent its flagship medical campus in Rochester, Minn., infusing digital technologies into several new buildings designed to present a 21st-century vision of clinical care, the organization said Tuesday. The project, to include five new buildings with 2.4

article thumbnail

Episode 599: Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients

Pharmacy Joe

Researchers recently published in Lancet a retrospective analysis of over 1000 patients in the Mayo Clinic database looking at mortality in patients with COVID-19 who received enoxaparin or unfractionated heparin (UFH). To access my free download area with 20 different resources to help you in your practice, go to pharmacyjoe.com/free.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 929: What is the incidence of torsades from low-dose ondansetron in peri-operative patients?

Pharmacy Joe

Researchers at the Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, Minnesota recently published a single center review evaluating the risk of torsades from a 4 mg dose of ondansetron IV in peri-operative patients.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

“This act…allowed a pathway for manufacturers to create a ‘copy’ of a licensed patent product to make it cheaper and more discounted,” Soefje, director of pharmacy cancer care services and associate professor of pharmacy at Mayo Clinic in Rochester, Minnesota, said at the HOPA conference.

article thumbnail

Episode 690: What is the incidence of torsades from low-dose ondansetron in peri-operative patients?

Pharmacy Joe

Researchers at the Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, Minnesota recently published a single center review evaluating the risk of torsades from a 4 mg dose of ondansetron IV in peri-operative patients.

article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patient care.